Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: the idiot who wrote (11930)	2/13/2019 2:58:16 PM
From: HardToFind	Respond to of 12873

No active and respected scientist independent from the company has ever vouched for the company's claims. Not a single one. Not Dr. Ken Rosenthal, who basically alerted NNVC to the fact that they were on the right track as far as herpes was concerned? Are you saying he's no longer active? Or that he's not respected? I don't know what you want to see here, but I would suggest that your expectations and mine differ markedly. I'm not going to waste time trying to prove you're wrong. You made the claim...why don't you back it up with evidence from press releases and how they have created the appearance of successful corroboration with industry leaders while dancing around actual support of their claims. Gene had bragged here frequently through his shills about having completed 3000 successful animal studies. Why did he do that? Why did they do that? How many more "animal studies" would have been necessary? I think the 3000 was animals, not studies, or is there a difference? And my recollection of the claim was without side effects or indications of toxicity...not necessarily a display of efficacy. Through numerous potential indications they were trying to optimize for a number of variables: ligand receptor mimicry, efficacy, backbone chain penetration through stomach walls and skin, safety for IV use, manufacturability, cost, various drug delivery vehicles. There is an awful lot wrong with this company and its management. Clearly, they appear to be ethically challenged...and in some domains, just plain stupid. Why not focus on the fact that they appear to be lying, overreaching, double-dealing, managerially incompetent, political control freaks with huge conflicts of interest and who cannot work to a schedule and have yet to hit a deliverable timeline? Why not focus on what you can show clear evidence of? But I was questioning the suspicion that Diwan was spiking the VZV nanoviricides with some other drug to show efficacy. I find raising that as a credible suspicion, without any corroborating evidence, to be preposterous. But that's just me.

To: the idiot who wrote (11930)	2/14/2019 2:31:53 PM
From: donpat	Respond to of 12873

Dear 'the idiot'; Did not that NNVC employee who joined NNVC come from USAMRID? Signed, Gene's shill Ref: Dr. Brian Friedrich zoominfo.com prnewswire.com "Viv Bonuik obviously didn't do the studies herself. She's a very old clinician with an opthamology practice. She hasn't worked in the lab for over half-century. She never publicly vouched for the company herself. She and her brother had a very huge financial incentive to keep things looking peachy to the public." I bet she has great eyesight! And a fat wallet.

To: the idiot who wrote (11930)	2/14/2019 4:56:22 PM
From: HardToFind	Respond to of 12873

She [V Boniuk] and her brother [Milton] had a very huge financial incentive to keep things looking peachy to the public. Which is why Milton Boniuk did not leave his post as NNVC board member and question Diwan's ethics on the way out...Oh wait, he did! You also leave out the obvious, that Boniuk was under no such incentive when doing due diligence prior to going headlong into the company. He may not have checked out Diwan well enough, but he likely checked out his area of expertise (which is the medicine) prior to entering into the deal. Or maybe he did no such due diligence at all...but I doubt it.